BAM
PFE icon

Belpointe Asset Management’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.92M Sell
120,284
-9,819
-8% -$238K 0.12% 150
2025
Q1
$3.3M Sell
130,103
-101,295
-44% -$2.57M 0.17% 112
2024
Q4
$6.71M Buy
231,398
+5,333
+2% +$155K 0.4% 44
2024
Q3
$6.54M Sell
226,065
-13,644
-6% -$395K 0.39% 44
2024
Q2
$6.71M Buy
239,709
+46,456
+24% +$1.3M 0.47% 35
2024
Q1
$5.36M Buy
193,253
+88,008
+84% +$2.44M 0.4% 44
2023
Q4
$3.03M Buy
105,245
+18,507
+21% +$533K 0.27% 70
2023
Q3
$2.88M Buy
86,738
+670
+0.8% +$22.2K 0.3% 62
2023
Q2
$3.16M Sell
86,068
-45,748
-35% -$1.68M 0.33% 60
2023
Q1
$5.38M Buy
131,816
+7,154
+6% +$292K 0.29% 53
2022
Q4
$6.39M Buy
124,662
+17,039
+16% +$873K 0.39% 40
2022
Q3
$4.71M Buy
107,623
+14,922
+16% +$653K 0.32% 59
2022
Q2
$4.86M Sell
92,701
-25,921
-22% -$1.36M 0.33% 55
2022
Q1
$6.14M Sell
118,622
-8,852
-7% -$458K 0.37% 44
2021
Q4
$7.53M Buy
127,474
+13,290
+12% +$785K 0.47% 33
2021
Q3
$4.91M Sell
114,184
-27,304
-19% -$1.17M 0.33% 53
2021
Q2
$5.54M Buy
141,488
+3,345
+2% +$131K 0.4% 42
2021
Q1
$5M Sell
138,143
-60,077
-30% -$2.18M 0.43% 35
2020
Q4
$7.3M Buy
198,220
+64,369
+48% +$2.37M 0.65% 22
2020
Q3
$4.91M Buy
133,851
+24,784
+23% +$909K 0.55% 29
2020
Q2
$3.57M Buy
109,067
+5,080
+5% +$166K 0.46% 38
2020
Q1
$3.39M Sell
103,987
-962
-0.9% -$31.4K 0.59% 30
2019
Q4
$4.11M Buy
104,949
+20,002
+24% +$784K 0.52% 36
2019
Q3
$3.05M Sell
84,947
-8,802
-9% -$316K 0.49% 36
2019
Q2
$4.06M Sell
93,749
-2,949
-3% -$128K 0.8% 22
2019
Q1
$4.11M Buy
96,698
+4,154
+4% +$176K 0.8% 22
2018
Q4
$4.04M Buy
92,544
+2,466
+3% +$108K 1.02% 11
2018
Q3
$3.97M Buy
90,078
+6,491
+8% +$286K 0.63% 23
2018
Q2
$3.03M Sell
83,587
-290
-0.3% -$10.5K 0.85% 16
2018
Q1
$2.98M Sell
83,877
-4,684
-5% -$166K 0.87% 14
2017
Q4
$3.21M Buy
88,561
+3,313
+4% +$120K 0.7% 21
2017
Q3
$3.04M Buy
+85,248
New +$3.04M 0.71% 20